The reality of dietary compliance in the management of phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 33, Issue 6, 2010, Pages 665-670

  MacDonald, Anita ^a   Van Rijn, Margreet ^b   Gokmen Ozel, Hulya ^c   Burgard, Peter ^d  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c HACETTEPE UNIVERSITY   (Turkey)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIET SUPPLEMENTATION; DIET THERAPY; DOCTOR PATIENT RELATION; FAMILY RELATION; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PHENYLKETONURIA; REVIEW; REWARD; SELF CONCEPT; SOCIAL SUPPORT; TREATMENT REFUSAL; ADOLESCENT; ADULT; ATTITUDE TO HEALTH; COOPERATION; ELEMENTAL DIET; EVALUATION; NUTRITION; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; COOPERATIVE BEHAVIOR; FOOD, FORMULATED; HUMANS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PATIENT COMPLIANCE; PHENYLKETONURIAS;

EID: 79952560803     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9073-y     Document Type: Review

References (37)

1. Bartels D (2004) Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control. J Am Acad Nurse Pract 16:8-16
2. Bekhof J, van Spronsen FJ, Crone MR, van Rijn M, Oudshoorn CGM, Verkerk PH (2003) Influence of knowledge of the disease on metabolic control in phenylketonuria. Eur J Pediatr 162:440-442 (Pubitemid 36693753)
3. Bilginsoy C, Waitzman N, Leonard CO, Ernst SL (2005) Living with phenylketonuria: perspectives of patients and their families. J Inherit Metab Dis 28:639-649 (Pubitemid 41349250)
4. Buist NR, Prince AP, Huntington KL, Tuerck JM, Waggoner DD (1994) A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatr Suppl 407:75-77, Erratum in: Acta Paediatr 1995; 84: 858
5. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155(Suppl 1):S33-S38
6. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296-1310 (Pubitemid 32804122)
7. Cramer JA, Roy A, Burrell A et al (2008) Medication compliance and persistence: terminology and definitions. Value Health 11:44-47 (Pubitemid 351160875)
8. Crone MR, van Spronsen FJ, Oudshoorn K, Bekhof J, van Rijn G, Verkerk PH (2005) Behavioural factors related to metabolic control in patients with phenylketonuria. J Inherit Metab Dis 28 (5):627-637 (Pubitemid 41349249)
9. Derose SF, Nakahiro RK, Ziel FH (2009) Automated messaging to improve compliance with diabetes test monitoring. Am J Manag Care 15:425-431
10. Dezii CM (2001) Persistence with drug therapy: a practical approach using administrative claims data. Manag Care 10:42-45
11. Durham-Shearer SJ, Judd PA, Whelan K, Thomas JE (2008) Knowledge, compliance and serum phenylalanine concentrations in adolescents and adults with phenylketonuria and the effect of a patient-focused educational resource. J Hum Nutr Diet 21:474-485
12. Evans S, Daly A, Hopkins V, Davies P, MacDonald A (2009) The impact of visual media to encourage low protein cooking in inherited metabolic disorders. J Hum Nutr Diet 22:409-413, Epub 2009 Apr 1
13. Gokmen Ozel H, Kucukkasap T, Koksal G, et al (2008) Does maternal knowledge impact blood phenylalanine concentrations in Turkish children with phenylketonuria? J Inherit Metab Dis Jun 27; E-pub ahead of print. doi:10.1007/s10545-008-0775-3.
14. Gokmen-Ozel H, Ahring K, Bélanger-Quintana A et al (2009) Blood phenylalanine control in PKU: a survey of ten European centres. Poster presentation; 11th International Congress of Inborn Errors of Metabolism, 29 August-2 September 2009, San Diego, CA, USA. Mol Genet Metab 98(1-2):30-31 (Abstract)
15. Hayes RB, Taylor WR, Sackett DL (eds) (1979) Compliance in health care. John Hopkins University Press, Baltimore, pp 1-2
16. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X (2008) Interventions for enhancing medication adherence. Cochrane Database Syst Rev Apr 16(2):CD000011
17. Hearnshaw H, Lindenmeyer A (2006) What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabetes Med 23:720-728 (Pubitemid 44366069)
18. Ipsiroglu OS, Herle M, Spoula E et al (2005) Transcultural pediatrics: compliance and outcome of phenylketonuria patients from families with an immigration background. Wien Klin Wochenschr 117:541-547 (Pubitemid 41336784)
19. Julius RJ, Novitsky MA Jr, Dubin WR (2009) Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 15:34-44
20. MacDonald A, Rylance G, Hall SK et al (1996) Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch Dis Child 74:412-417 (Pubitemid 26000228)
21. MacDonald A, Rylance GW, Asplin D et al (1998) Does a single plasma phenylalanine predict quality of control in phenylketonuria? Arch Dis Child 78:122-126
22. MacDonald A, Manji N, Evans S et al (2006a) Home delivery of dietary products in inherited metabolic disorders reduces prescription and dispensing errors. J Hum Nutr Diet 19:375-381 (Pubitemid 44363607)
23. MacDonald A, Lilburn M, Davies P et al (2006b) 'Ready to drink' protein substitute is easier for people with phenylketonuria. J Inherit Metab Dis 29:526-531 (Pubitemid 44193266)
24. MacDonald A, Chakrapani A, Hendriksz C et al (2006c) Protein substitute dosage in PKU: how much do young patients need? Arch Dis Child 91:588-593
25. MacDonald A, Davies P, Daly A et al (2008) Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria. J Hum Nutr Diet 21:351-358 (Pubitemid 352044728)
26. Marinker M (2000) Achieving concordance. Prim Care Pharm 1:93-95, Retrieved from http://www.pharmj.com/PrimaryCarePharmacy/200009/comment/ viewpoint-concordance.html on 12 August 2009
27. Nevins TE (2005) "Why do they do that?" The compliance conundrum. Pediatr Nephrol 20:845-848
28. Olsson GM, Montgomery SM, Alm J (2007) Family conditions and dietary control in phenylketonuria. J Inherit Metab Dis 30:708-715 (Pubitemid 47559883)
29. Playle JF, Keeley P (1998) Non-compliance and professional power. J Adv Nurs 27:304-311 (Pubitemid 128452677)
30. van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis 31:673-679
31. van Spronsen FJ, van Rijn M, van Dijk T et al (1993) Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/ postprandial) in patients with phenylketonuria: effect of sample timing. Pediatrics 92:570-573
32. van Spronsen FJ, van Dijk T, Smit GPA et al (1996) Phenylketonuria: Plasma responses to different distributions of the daily phenylalanine allowance over the day. Pediatrics 97:839-844 (Pubitemid 26170944)
33. Velligan DI, Wang M, Diamond P et al (2007) Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 58:1187-1192 (Pubitemid 47507958)
34. Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26:331-42 (Pubitemid 32989555)
35. Walter JH, White FJ, Hall SK et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55-57
36. World Health Organization (2003) Adherence to long term therapies: evidence for action. WHO, Geneva. http://www.who.int/chp/knowledge/publications/ adherence-introduction.pdf. Accessed 12 Aug 2009
37. Zeman J, Pijackova A, Behulova J, Urge O, Saligova D, Hyanek J (1996) Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak Collaborative Study. Eur J Pediatr 155(Suppl 1):S56-S58 (Pubitemid 126721393)